John Potthoff Joins RQM+ as CEO
May 09 2024 - 10:00AM
Business Wire
Potthoff Becomes CEO as Margaret Keegan Focuses
on Role Within Linden
RQM+, a leading global MedTech contract research organization
(CRO), today announced John Potthoff, Ph.D., as its new CEO. This
transition comes as former CEO, Margaret Keegan, announced she
plans to move out of day-to-day operations to focus on her role as
an operating partner with Linden Capital Partners. Margaret will
remain on the board of RQM+.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240509890767/en/
John Potthoff (right) joins MedTech
leader RQM+ as its new CEO as Margaret Keegan, former CEO,
announced her decision to transition to focusing on her role as an
operating partner with Linden Capital Partners and will remain on
the board of RQM+. (Photo: Business Wire)
John, co-founder and former CEO of Elligo Health Research®, has
been on the RQM+ board since 2021. He brings extensive MedTech
industry expertise to his new role as CEO of RQM+. Prior to Elligo,
he was CEO of Theorem Clinical Research, which had a significant
global med device and diagnostics business unit, and was also the
chief operating officer at INC Research.
“During Margaret’s tenure, she completed three acquisitions and
made significant progress in creating an end-to-end MedTech CRO at
RQM+,” John said. “I look forward to building on this remarkable
foundation and continuing to drive growth and advance global
healthcare through MedTech innovation.”
As a board member of RQM+, Margaret will continue to assist the
company in executing its core priorities. “I am extremely proud of
the RQM+ team's many accomplishments,” she said. “While I’ll be
stepping away from day-to-day operations, I look forward to
continuing to support the company. I believe John is a proven
leader and is very knowledgeable about the company and our
industry. He is well-positioned to lead and enhance RQM+ to meet
the ever-changing MedTech industry needs now and into the
future.”
About RQM+
RQM+ is a leading MedTech service provider offering consulting,
clinical trial, lab, and reimbursement services, as well as
technology solutions to support the entire product lifecycle.
RQM+’s global team of clinical, technical, and industry experts
push the boundaries of excellence. With former FDA, Medicines, and
Healthcare Products Regulatory Agency (MHRA) and notified body
regulators, RQM+ has deep expertise in all clinical specialties. We
reduce commercialization risk by offering a full complement of CRO
services to progress medical devices, digital therapeutics and
diagnostics onto the market and keep them there. In addition to
early- and mid-stage MedTech companies, we currently work with 19
of the top 20 medical device manufacturers and seven of the top 10
IVD companies.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240509890767/en/
Lindsey Langemeier SCORR Marketing +1 402-405-4269
pr@scorrmarketing.com